United States · FDA National Drug Code directory
Cefazolin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9665_a1fc6bdd-6f1b-402f-9e84-b6e5ed5febb4
- Product NDC
- 0143-9665
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Cefazolin
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041018
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFAZOLIN SODIUM — 20 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9665-10) · 0143-9665-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →